4.4 Review

Olfactory hallucinations in primary headache disorders: Case series and literature review

Journal

CEPHALALGIA
Volume 31, Issue 14, Pages 1477-1489

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102411423315

Keywords

Migraine; aura; olfactory aura; olfactory hallucinations; phantosmia

Funding

  1. Allergan, Inc
  2. St Jude Medical
  3. OrthoMcNeil Pharmaceuticals
  4. GlaxoSmithKline, Inc
  5. Merck Co, Inc
  6. Advanced Bionics
  7. Proethics
  8. Pfizer, Inc.

Ask authors/readers for more resources

Background: Olfactory hallucinations (phantosmias) have rarely been reported in migraine patients. Unlike visual, sensory, language, brainstem, and motor symptoms, they are not recognized as a form of aura by the International Classification of Headache Disorders. Methods: We examined the clinical features of 39 patients (14 new cases and 25 from the literature) with olfactory hallucinations in conjunction with their primary headache disorders. Results: In a 30-month period, the prevalence of phantosmias among all patients seen at our headache center was 0.66%. Phantosmias occurred most commonly in women with migraine, although they were also seen in several patients with other primary headache diagnoses. The typical hallucination lasted 5-60 minutes, occurred shortly before or simultaneous with the onset of head pain, and was of a highly specific and unpleasant odor, most commonly a burning smell. In the majority of patients, phantosmias diminished or disappeared with initiation of prophylactic therapy for headaches. Conclusions: We propose that olfactory hallucinations are probably an uncommon but distinctive form of migraine aura, based on their semiology, timing and response to headache prophylaxis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available